Previous studies have shown that NPY signaling stimulates cancer cell motility and invasive potential in vitro in breast and prostate cancer cell lines (49, 50, 80, 81), warranting further investigation of the role of NPY1R in PC cell migration. Here, NPY1R is linked to prostate cancer.